Search results for "continuous" in Articles / App Notes
Article
Next Generation Bioprocesses: Mapping Roads to the Future
They include semi-continuous and continuous approaches, focus on operational excellence, implementation of disruptive technologies both up- and downstream, or supplier partnership. This article will c…
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
The advances in upstream titers are reflected in survey responses regarding the top areas industry needs to address to avoid future capacity constraints, with developing better continuous and better o…
Article
Reliability Rooms and the Move to Proactive Supply Chain Management
Reliability Rooms and the Move to Proactive Supply Chain Management
Cross-functional reliability rooms identify risk and planning metrics, provide insights for production forecasts, and predict tren…
Article
Platform Technologies Improve Protein Expression
In addition to exploring novel production methods such as continuous processes and disposable production technology, manufacturers also heavily invest in platform technologies for protein expression t…
Article
From Darwin to Recombinant Fc Multimers
Posters topics covered: Continuous chromatography in plasma applications, Viral clearance study optimization for virus filters, Buffer management via in-line conditioning systems, Radial flow chromato…
Article
Drug Quality Key to Innovation and Access
FDA plans to advance initiatives for ensuring reliable production of drugs and biologics in 2017.
By Jill Wechsler
Amidst multiple challenges to the structure and governance of the US health…
Article
A Q&A with Eric Langer: CMOs Embrace New Technology
However, this year, ‘Continuous Bioprocessing: Downstream’ – a new option – rises to the top of the list (36.6%). This may not be too surprising given the large increase this year in respondents seein…
Article
Innovative Therapies Require Modern Manufacturing Systems
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.
By Jill Wechsler
FDA set a 19-year record in 2015 in approving more new drugs and biologics, and …
Article
Framing Biopharma Success in 2016
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
By Rita C. Peters
The US biopharmaceutical industry turned a new page in 2015 when…
Article
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
Microbial contamination of continuous cell cultures by a wide variety of microorganisms is also problematic in cell culture laboratories worldwide, particularly by mycoplasma. The latter can be diffic…